Foresight Backs Envoke Lab Software Firm with £1.6M

Foresight Group has injected £1.6 million into Envoke, a UK-based innovator in laboratory simulation software. This growth capital infusion is set to accelerate the company's international expansion, with a particular focus on the dynamic Asia-Pacific market.

Founded in Leeds in 2019, Envoke has carved a niche by developing sophisticated software that creates virtual replicas of complex laboratory equipment. This technology facilitates remote training, diagnostics, and support, significantly reducing the reliance on costly and time-consuming on-site engineering interventions. The platform's ability to simulate real-world scenarios empowers laboratory staff with enhanced skills and streamlines troubleshooting processes.

The impact of Envoke's solution is already evident. Major global manufacturers of laboratory apparatus and prominent healthcare organizations in the UK and US are leveraging its capabilities. Early adopters have reported a reduction in service callouts by an impressive 15-20%. This efficiency gain not only lowers operational expenses for equipment providers but also ensures greater uptime for critical laboratory machinery, a vital factor in research and diagnostics.

Beyond cost savings, Envoke's software provides invaluable data analytics on user proficiency. This insight allows organizations to identify training deficiencies and understand their direct correlation with laboratory performance, enabling targeted improvements. The company's recent success in acquiring new international clients underscores the growing global demand for advanced virtual training and remote maintenance solutions in the scientific and healthcare sectors.

Looking ahead, Envoke anticipates surpassing £1 million in annual recurring revenue within the next twelve months. The company also plans to expand its UK-based team by hiring three to five new professionals over the coming year. This strategic investment from Foresight, a seasoned private equity and real assets manager with a strong track record in supporting growth-stage companies, is expected to be a catalyst for achieving these ambitious targets.

Line Gauteplass, Senior Investment Manager at Foresight, commented on the investment, stating, “Envoke presents a powerful platform addressing critical operational needs for both laboratory equipment manufacturers and healthcare providers. Their demonstrated success with leading global clients, coupled with our strategic vision for international growth, particularly in the Asia-Pacific region, makes this an exciting partnership. We are eager to support Stuart and the Envoke team as they embark on this next significant growth phase.”

The laboratory equipment market, a sector experiencing consistent innovation and demand driven by advancements in life sciences and healthcare, presents fertile ground for Envoke's technology. The increasing complexity of scientific instrumentation and the global push for operational efficiency further amplify the value proposition of remote simulation and support solutions. Envoke's strategic expansion, backed by Foresight's financial and operational expertise, positions it to capture a substantial share of this evolving market.